Hypoparathyroidism Natural History Study

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT05793853
Status
Recruiting
Apply to this trial

Conditions

  • Hypoparathyroidism

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Accepted

Study Details

This is a prospective three-year natural history study of adults with hypoparathyroidism. The goal is to monitor patients with hypoparathyroidism to define end-organ damage in the context of the disease. The study objectives are to: 1. Build a prospective cohort of patients to study HPT-associated end-organ damage. 2. Determine end-organ physiologic consequences of HPT. 3. Elucidate determinants of HPT-associated end-organ damage. Funding Source - FDA OOPD

Key Dates

First listed
Mar 31, 2023
Start date
Aug 25, 2022
Status verified
Dec 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
106 participants (estimated)

Arms

  • Arm: Hypoparathyroidism Subjects
    Patients who have the disease hypoparathyroidism, who are being followed to monitor various aspects of the disease over time. No interventions.
  • Arm: Control Subjects
    Healthy individuals to be followed to compare to hypoparathyroidism patients

Primary Outcome Measure

Kidney function [ Time Frame: baseline, 6, 12, 18, 24, 30, 36 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Columbia University Medical Center - Harkness PavillionNew YorkNew York10032
Noelle Texeira
[email protected]
212-305-2801
Mishaela Rubin, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Columbia University Medical Center - Harkness Pavillion· New York, NY

Related Studies